Urinary incontinence: an unrecognised adverse effect with donepezil.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 10950240.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Donepezil has been licensed for use in Japan to improve cognitive function since 1999. Among 94 patients with probable Alzheimer's disease who we treated with donepezil, seven patients developed urinary incontinence, although this event was transient in most patients.